|
| Status |
Public on Jun 14, 2019 |
| Title |
RNAseq of prostate cancer cells (PC3 and DU145) treated with 2.5 uM pentamidine or vehicle |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
To uncover the mechanism underlying the effect of pentamidine on prostate cancer cells, we performed RNA sequencing (RNA-seq) to compare the transcriptional difference between pentamidine- and vehicle-treated prostate cancer cells (PC3 and DU145 cells).
|
| |
|
| Overall design |
mRNA profiles of PC3 and DU145 cells treated with 2.5 uM pentamidine or vehicle were generated by deep sequencing, in triplicate, using Illumina Novaseq 6000 PE150.
|
| |
|
| Contributor(s) |
Liu L |
| Citation(s) |
31721355 |
| Submission date |
Jun 13, 2019 |
| Last update date |
Dec 25, 2019 |
| Contact name |
Lin Liu |
| E-mail(s) |
55319872@163.com
|
| Organization name |
Shanghai Jiao Tong University
|
| Department |
Renji‐Med X Clinical Stem Cell Research Center, Ren Ji Hospital
|
| Lab |
State Key Laboratory of Oncogenes and Related Genes
|
| Street address |
Shanghai
|
| City |
Shanghai |
| State/province |
Shanghai |
| ZIP/Postal code |
222110 |
| Country |
China |
| |
|
| Platforms (1) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (12)
|
|
| Relations |
| BioProject |
PRJNA548765 |
| SRA |
SRP201339 |
Less...
More...